Mycobacterium tuberculosis virulence: insights and impact on vaccine development
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Mycobacterium tuberculosis virulence: insights and impact on vaccine development
Authors
Keywords
-
Journal
Future Microbiology
Volume 10, Issue 7, Pages 1177-1194
Publisher
Future Medicine Ltd
Online
2015-06-29
DOI
10.2217/fmb.15.26
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Tuberculosis vaccine development at a divide
- (2014) Stefan H.E. Kaufmann CURRENT OPINION IN PULMONARY MEDICINE
- Oral Vaccination with Heat Inactivated Mycobacterium bovis Activates the Complement System to Protect against Tuberculosis
- (2014) Beatriz Beltrán-Beck et al. PLoS One
- Mycobacterium tuberculosis Requires the ECF Sigma Factor SigE to Arrest Phagosome Maturation
- (2014) Stefano Casonato et al. PLoS One
- Pro- and anti-inflammatory cytokines in tuberculosis: A two-edged sword in TB pathogenesis
- (2014) Marilena Paola Etna et al. SEMINARS IN IMMUNOLOGY
- Macrophage immunoregulatory pathways in tuberculosis
- (2014) Murugesan V.S. Rajaram et al. SEMINARS IN IMMUNOLOGY
- Perspectives on host adaptation in response to Mycobacterium tuberculosis: Modulation of inflammation
- (2014) Anca Dorhoi et al. SEMINARS IN IMMUNOLOGY
- Tuberculosis vaccines – rethinking the current paradigm
- (2014) Peter Andersen et al. TRENDS IN IMMUNOLOGY
- Homologous prime boosting based on intranasal delivery of non-pathogenic invasive Escherichia coli expressing MPT64, decreases Mycobacterium tuberculosis dissemination
- (2014) Michela Sali et al. VACCINE
- Therapeutic vaccines for tuberculosis—A systematic review
- (2014) Matthias I. Gröschel et al. VACCINE
- Mycobacterial Membrane Vesicles Administered Systemically in Mice Induce a Protective Immune Response to Surface Compartments of Mycobacterium tuberculosis
- (2014) R. Prados-Rosales et al. mBio
- Sequence Diversity in the pe_pgrs Genes of Mycobacterium tuberculosis Is Independent of Human T Cell Recognition
- (2014) R. Copin et al. mBio
- Novel Vaccination Strategies against Tuberculosis
- (2014) P. Andersen et al. Cold Spring Harbor Perspectives in Medicine
- Innovative Strategies to Identify M. tuberculosis Antigens and Epitopes Using Genome-Wide Analyses
- (2014) Annemieke Geluk et al. Frontiers in Immunology
- The Immune Response in Tuberculosis
- (2013) Anne O'Garra et al. Annual Review of Immunology
- Antibody-Mediated Immunity against Tuberculosis: Implications for Vaccine Development
- (2013) Jacqueline M. Achkar et al. Cell Host & Microbe
- ESX-1-induced apoptosis is involved in cell-to-cell spread ofMycobacterium tuberculosis
- (2013) J. I. Aguilo et al. CELLULAR MICROBIOLOGY
- Critical research concepts in tuberculosis vaccine development
- (2013) G. Delogu et al. CLINICAL MICROBIOLOGY AND INFECTION
- Mucosal delivery of antigen-coated nanoparticles to lungs confers protective immunity against tuberculosis infection in mice
- (2013) Elena Stylianou et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Tuberculosis: Time for a new perspective?
- (2013) Paul T. Elkington JOURNAL OF INFECTION
- Safety and efficacy of MVA85A, a new tuberculosis vaccine, in infants previously vaccinated with BCG: a randomised, placebo-controlled phase 2b trial
- (2013) Michele D Tameris et al. LANCET
- A major event for new tuberculosis vaccines
- (2013) Christopher Dye et al. LANCET
- Vaccination with Recombinant Mycobacterium tuberculosis PknD Attenuates Bacterial Dissemination to the Brain in Guinea Pigs
- (2013) Ciaran Skerry et al. PLoS One
- Secreted Acid Phosphatase (SapM) of Mycobacterium tuberculosis Is Indispensable for Arresting Phagosomal Maturation and Growth of the Pathogen in Guinea Pig Tissues
- (2013) Rupangi Verma Puri et al. PLoS One
- ESAT-6 (EsxA) and TB10.4 (EsxH) Based Vaccines for Pre- and Post-Exposure Tuberculosis Vaccination
- (2013) Truc Hoang et al. PLoS One
- The ESX-3 Secretion System Is Necessary for Iron and Zinc Homeostasis in Mycobacterium tuberculosis
- (2013) Agnese Serafini et al. PLoS One
- A review of preclinical animal models utilised for TB vaccine evaluation in the context of recent human efficacy data
- (2013) Helen McShane et al. TUBERCULOSIS
- A new unifying theory of the pathogenesis of tuberculosis
- (2013) Ian M. Orme TUBERCULOSIS
- Characterization of W-Beijing isolates of Mycobacterium tuberculosis from the Western Cape
- (2013) Crystal A. Shanley et al. VACCINE
- Preventive vaccines for tuberculosis
- (2013) Thomas G. Evans et al. VACCINE
- Safety and immunogenicity of the recombinant BCG vaccine VPM1002 in a phase 1 open-label randomized clinical trial
- (2013) Leander Grode et al. VACCINE
- Construction, characterization and preclinical evaluation of MTBVAC, the first live-attenuated M. tuberculosis-based vaccine to enter clinical trials
- (2013) Ainhoa Arbues et al. VACCINE
- Comparison of the immunogenicity and protection against bovine tuberculosis following immunization by BCG-priming and boosting with adenovirus or protein based vaccines
- (2013) G. Dean et al. VACCINE
- Exploiting the mycobacterial cell wall to design improved vaccines against tuberculosis
- (2013) Matteo Morandi et al. Journal of Infection in Developing Countries
- Virulence factors of theMycobacterium tuberculosiscomplex
- (2013) Marina A. Forrellad et al. Virulence
- Memory T Cells in Latent Mycobacterium tuberculosis Infection Are Directed against Three Antigenic Islands and Largely Contained in a CXCR3+CCR6+ Th1 Subset
- (2013) Cecilia S. Lindestam Arlehamn et al. PLoS Pathogens
- Pattern Recognition Receptors and Cytokines inMycobacterium tuberculosisInfection—The Double-Edged Sword?
- (2013) Md. Murad Hossain et al. Biomed Research International
- ESX-1-induced apoptosis during mycobacterial infection: to be or not to be, that is the question
- (2013) Nacho Aguiló et al. Frontiers in Cellular and Infection Microbiology
- Functional dissection of protein domains involved in the immunomodulatory properties of PE_PGRS33 ofMycobacterium tuberculosis
- (2013) Antonella Zumbo et al. Pathogens and Disease
- Microbial Scout Hypothesis, Stochastic Exit from Dormancy, and the Nature of Slow Growers
- (2012) S. Buerger et al. APPLIED AND ENVIRONMENTAL MICROBIOLOGY
- Mycobacterium tuberculosis Inhibits Neutrophil Apoptosis, Leading to Delayed Activation of Naive CD4 T cells
- (2012) Robert Blomgran et al. Cell Host & Microbe
- Identification of theMycobacterium tuberculosisprotein PE-PGRS62 as a novel effector that functions to block phagosome maturation and inhibit iNOS expression
- (2012) Emily P. Thi et al. CELLULAR MICROBIOLOGY
- ESX-1-mediated translocation to the cytosol controls virulence of mycobacteria
- (2012) Diane Houben et al. CELLULAR MICROBIOLOGY
- The Mycobacterium tuberculosis SecA2 System Subverts Phagosome Maturation To Promote Growth in Macrophages
- (2012) Jonathan Tabb Sullivan et al. INFECTION AND IMMUNITY
- A rational vaccine pipeline for tuberculosis [State of the art series. New tools. Number 5 in the series]
- (2012) M. J. Brennan et al. INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE
- Host-pathogen coevolution in human tuberculosis
- (2012) S. Gagneux PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES
- Conserved Immune Recognition Hierarchy of Mycobacterial PE/PPE Proteins during Infection in Natural Hosts
- (2012) H. Martin Vordermeier et al. PLoS One
- Resuscitation-promoting Factors (Rpf): In Search of Inhibitors
- (2012) Arseny S. Kaprelyants et al. PROTEIN AND PEPTIDE LETTERS
- The heterogeneous evolution of multidrug-resistant Mycobacterium tuberculosis
- (2012) Borna Müller et al. TRENDS IN GENETICS
- Creativity in tuberculosis research and discovery
- (2012) Douglas Younga et al. TUBERCULOSIS
- Tuberculosis Vaccines: A Strategic Blueprint for the Next Decade
- (2012) Michael J. Brennan et al. TUBERCULOSIS
- A recombinant adenovirus expressing immunodominant TB antigens can significantly enhance BCG-induced human immunity
- (2012) Daniel F. Hoft et al. VACCINE
- Vaccines against Tuberculosis: Where Are We and Where Do We Need to Go?
- (2012) Tom H. M. Ottenhoff et al. PLoS Pathogens
- Linking the Transcriptional Profiles and the Physiological States of Mycobacterium tuberculosis during an Extended Intracellular Infection
- (2012) Kyle H. Rohde et al. PLoS Pathogens
- PE_PGRS30 is required for the full virulence of Mycobacterium tuberculosis
- (2011) Raffaella Iantomasi et al. CELLULAR MICROBIOLOGY
- Identification of Human T-Cell Responses to Mycobacterium tuberculosis Resuscitation-Promoting Factors in Long-Term Latently Infected Individuals
- (2011) Susanna Commandeur et al. Clinical and Vaccine Immunology
- Mycobacteria release active membrane vesicles that modulate immune responses in a TLR2-dependent manner in mice
- (2011) Rafael Prados-Rosales et al. JOURNAL OF CLINICAL INVESTIGATION
- The multistage vaccine H56 boosts the effects of BCG to protect cynomolgus macaques against active tuberculosis and reactivation of latent Mycobacterium tuberculosis infection
- (2011) Philana Ling Lin et al. JOURNAL OF CLINICAL INVESTIGATION
- ESAT-6 Secretion-Independent Impact of ESX-1 Genes espF and espG1 on Virulence of Mycobacterium tuberculosis
- (2011) Daria Bottai et al. JOURNAL OF INFECTIOUS DISEASES
- Fact and fiction in tuberculosis vaccine research: 10 years later
- (2011) Stefan HE Kaufmann LANCET INFECTIOUS DISEASES
- Apoptosis is an innate defense function of macrophages against Mycobacterium tuberculosis
- (2011) S M Behar et al. Mucosal Immunology
- A recombinant Mycobacterium smegmatis induces potent bactericidal immunity against Mycobacterium tuberculosis
- (2011) Kari A Sweeney et al. NATURE MEDICINE
- A multistage tuberculosis vaccine that confers efficient protection before and after exposure
- (2011) Claus Aagaard et al. NATURE MEDICINE
- Lysine Auxotrophy Combined with Deletion of the SecA2 Gene Results in a Safe and Highly Immunogenic Candidate Live Attenuated Vaccine for Tuberculosis
- (2011) Joseph Hinchey et al. PLoS One
- Mycobacterium tuberculosis protein tyrosine phosphatase (PtpA) excludes host vacuolar-H+-ATPase to inhibit phagosome acidification
- (2011) D. Wong et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Taking a New Shot At a TB Vaccine
- (2011) K. Kupferschmidt SCIENCE
- Ag85B–ESAT-6 adjuvanted with IC31® promotes strong and long-lived Mycobacterium tuberculosis specific T cell responses in volunteers with previous BCG vaccination or tuberculosis infection
- (2011) Jaap T. van Dissel et al. VACCINE
- Targeting of Mycobacterium tuberculosis Heparin-Binding Hemagglutinin to Mitochondria in Macrophages
- (2011) Hosung Sohn et al. PLoS Pathogens
- Letting Sleeping dos Lie: Does Dormancy Play a Role in Tuberculosis?
- (2010) Michael C. Chao et al. Annual Review of Microbiology
- Evaluation of the Safety and Immunogenicity of Two Antigen Concentrations of the Mtb72F/AS02A Candidate Tuberculosis Vaccine in Purified Protein Derivative-Negative Adults
- (2010) I. Leroux-Roels et al. Clinical and Vaccine Immunology
- Future Vaccination Strategies against Tuberculosis: Thinking outside the Box
- (2010) Stefan H.E. Kaufmann IMMUNITY
- Immunogenicity and Protection Induced by a Mycobacterium tuberculosis sigE Mutant in a BALB/c Mouse Model of Progressive Pulmonary Tuberculosis
- (2010) R. H. Pando et al. INFECTION AND IMMUNITY
- Surface Expression of MPT64 as a Fusion with the PE Domain of PE_PGRS33 Enhances Mycobacterium bovis BCG Protective Activity against Mycobacterium tuberculosis in Mice
- (2010) M. Sali et al. INFECTION AND IMMUNITY
- Region of Difference 2 Contributes to Virulence ofMycobacterium tuberculosis
- (2010) Robert A. Kozak et al. INFECTION AND IMMUNITY
- Human T cell epitopes of Mycobacterium tuberculosis are evolutionarily hyperconserved
- (2010) Iñaki Comas et al. NATURE GENETICS
- Mycobacterial Nucleoside Diphosphate Kinase Blocks Phagosome Maturation in Murine Raw 264.7 Macrophages
- (2010) Jim Sun et al. PLoS One
- Interactions of Attenuated Mycobacterium tuberculosis phoP Mutant with Human Macrophages
- (2010) Nadia L. Ferrer et al. PLoS One
- Induction of ER Stress in Macrophages of Tuberculosis Granulomas
- (2010) Tracie A. Seimon et al. PLoS One
- Portrait of a Pathogen: The Mycobacterium tuberculosis Proteome In Vivo
- (2010) Nicole A. Kruh et al. PLoS One
- A Defined Tuberculosis Vaccine Candidate Boosts BCG and Protects Against Multidrug-Resistant Mycobacterium tuberculosis
- (2010) S. Bertholet et al. Science Translational Medicine
- The mechanisms and consequences of the extra-pulmonary dissemination of Mycobacterium tuberculosis
- (2010) Nitya Krishnan et al. TUBERCULOSIS
- Higher human CD4 T cell response to novel Mycobacterium tuberculosis latency associated antigens Rv2660 and Rv2659 in latent infection compared with tuberculosis disease
- (2010) Lerisa Govender et al. VACCINE
- The second Geneva Consensus: Recommendations for novel live TB vaccines
- (2010) K.B. Walker et al. VACCINE
- The Type I NADH Dehydrogenase of Mycobacterium tuberculosis Counters Phagosomal NOX2 Activity to Inhibit TNF-α-Mediated Host Cell Apoptosis
- (2010) Jessica L. Miller et al. PLoS Pathogens
- Hypoxia Induces an Immunodominant Target of Tuberculosis Specific T Cells Absent from Common BCG Vaccines
- (2010) Hannah Priyadarshini Gideon et al. PLoS Pathogens
- The Role of the Granuloma in Expansion and Dissemination of Early Tuberculous Infection
- (2009) J. Muse Davis et al. CELL
- Modified vaccinia Ankara-expressing Ag85A, a novel tuberculosis vaccine, is safe in adolescents and children, and induces polyfunctional CD4+ T cells
- (2009) Thomas J. Scriba et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- A Dynamic Reinfection Hypothesis of Latent Tuberculosis Infection
- (2009) P.-J. Cardona INFECTION
- Characterization of a Mycobacterium tuberculosis ESX-3 Conditional Mutant: Essentiality and Rescue by Iron and Zinc
- (2009) A. Serafini et al. JOURNAL OF BACTERIOLOGY
- Identification of T-Cell Antigens Specific for Latent Mycobacterium Tuberculosis Infection
- (2009) Sebastian D. Schuck et al. PLoS One
- MVA.85A Boosting of BCG and an Attenuated, phoP Deficient M. tuberculosis Vaccine Both Show Protective Efficacy Against Tuberculosis in Rhesus Macaques
- (2009) Frank A. W. Verreck et al. PLoS One
- Epidemiological benefits of more-effective tuberculosis vaccines, drugs, and diagnostics
- (2009) L. J. Abu-Raddad et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Eliminating latent tuberculosis
- (2009) Douglas B. Young et al. TRENDS IN MICROBIOLOGY
- Novel recombinant BCG expressing perfringolysin O and the over-expression of key immunodominant antigens; pre-clinical characterization, safety and protection against challenge with Mycobacterium tuberculosis
- (2009) Ronggai Sun et al. VACCINE
- The quest for a new vaccine against tuberculosis
- (2009) Giovanni Delogu et al. Journal of Infection in Developing Countries
- Mycobacterium tuberculosis Prevents Inflammasome Activation
- (2008) Sharon S. Master et al. Cell Host & Microbe
- Immunogenicity and Protective Efficacy of Prime-Boost Regimens with Recombinant ureC hly+ Mycobacterium bovis BCG and Modified Vaccinia Virus Ankara Expressing M. tuberculosis Antigen 85A against Murine Tuberculosis
- (2008) E. Z. Tchilian et al. INFECTION AND IMMUNITY
- Incorporation of Mycobacterium tuberculosis Lipoarabinomannan into Macrophage Membrane Rafts Is a Prerequisite for the Phagosomal Maturation Block
- (2008) A. Welin et al. INFECTION AND IMMUNITY
- Delayed protection by ESAT-6–specific effector CD4+T cells after airborneM. tuberculosisinfection
- (2008) Alena M. Gallegos et al. JOURNAL OF EXPERIMENTAL MEDICINE
- LspA inactivation in Mycobacterium tuberculosis results in attenuation without affecting phagosome maturation arrest
- (2008) S. K. Rampini et al. MICROBIOLOGY-SGM
- The Enduring Hypoxic Response of Mycobacterium tuberculosis
- (2008) Tige R. Rustad et al. PLoS One
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation